The DOI matches its Crossref record; 34 of the 35 references it cites were found in a registry or an index.
Prevalence of obesity in type 2 diabetes in secondary care: association with cardiovascular risk factors
Open accessAbstract
Aims: To determine the prevalence of overweight and obesity among patients with type 1 and type 2 diabetes mellitus attending a secondary care diabetes clinic in the United Kingdom, and to assess the impact of overweight and obesity on glycaemic control and cardiovascular risk factors in patients with type 2 diabetes. Methods: 3637 patients with diabetes were identified from the hospital electronic diabetes register, 916 with type 1 diabetes (mean (SD) age 40.4 (15.1) years, 496 male) and 2721 with type 2 diabetes (mean (SD) age 62.5 (11.8) years, 1436 male). Data on body mass index (BMI), glycaemic control, lipid profiles, and blood pressure were extracted. Results: Of patients with type 1 diabetes, 55.3% were overweight (BMI ⩾25 kg/m2), 16.6% were obese (BMI ⩾30 kg/m2), and 0.4% had morbid obesity (BMI ⩾40 kg/m2). In contrast, 86% of patients with type 2 diabetes were overweight or obese, 52% were obese, and 8.1% had morbid obesity. Obese patients with type 2 diabetes were younger, had poorer glycaemic control, higher blood pressures, worse lipid profiles, and were more likely to be receiving antihypertensive and lipid lowering drugs compared with patients with BMI <30 kg/m2. Conclusions: Obesity is the rule among patients attending this hospital diabetes clinic, with 86% of those with type 2 diabetes overweight or obese. Obesity is associated with significantly worse cardiovascular risk factors in this patient group, suggesting that more active interventions to control weight gain would be appropriate.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, patients with T2DM are more likely to be overweight or obese, which indicates insulin resistance and dyslipidemia along with hyperglycemia [5, 6].”
From The Effect of Berberine on Metabolic Profiles in Type 2 Diabetic Patients: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials (2021) · cites this paper as [5]
In the citing paper
“Dysglycemia is strongly associated with the development of overweight status or obesity, as most DM2 patients are overweight or obese (44–46).”
From GDF-15 as a Weight Watcher for Diabetic and Non-Diabetic People Treated With Metformin (2020) · cites this paper as [46]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
(2000) · PubMed · Cited by 13,173
Obesity : Preventing and managing the global epidemic
Akram, D. S., Astrup, A. V., Atinmo, T., Boissin, J.-L., Bray, G. A., Carroll, K. N., Chitson, P., Chen, C., Dietz, W. H., Hill, J. O., et al. (2000) · Research at the University of Copenhagen (University of Copenhagen) · Cited by 12,945
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873
Turner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
Pan, X.-R., Li, G.-W., Hu, Y.-H., Wang, J.-X., Yang, W.-Y., An, Z.-X., Hu, Z.-X., Juan-Lin, Xiao, J.-Z., Cao, H.-B., et al. (1997) · Diabetes Care · doi:10.2337/diacare.20.4.537 · Cited by 4,320
Gupta, A., & Uribarri, J. (2016) · Hormone Research in Paediatrics · doi:10.1159/000444053 · Cited by 4,023
Diabetes and Cardiovascular Disease: The Framingham Study
Kannel, W. B. (1979) · JAMA · doi:10.1001/jama.1979.03290450033020 · Cited by 2,936
Fuller, N. R., Colagiuri, S., SCHOFIELD, D. J., Olson, A. D., Shrestha, R. N., Holzapfel, C., Wolfenstetter, S. B., Holle, R., Ahern, A. L., Hauner, H., et al. (2012) · International Journal of Obesity · doi:10.1038/ijo.2012.139 · Cited by 2,127
XENical in the Prevention of Diabetes in Obese Subjects (XENDOS) Study
Torgerson, J. S., Hauptman, J., Boldrin, M. N., & Sjöström, L. (2004) · Diabetes Care · doi:10.2337/diacare.27.1.155 · Cited by 1,915
A Prospective Study of Obesity and Risk of Coronary Heart Disease in Women
Manson, J. E., Colditz, G. A., Stampfer, M. J., Willett, W. C., ROSNER, B. A., Monson, R. R., Speizer, F. E., & Hennekens, C. H. (1990) · New England Journal of Medicine · doi:10.1056/nejm199003293221303 · Cited by 1,403
Diabetes and cardiovascular disease
Howard, B. V., & Magee, M. F. (2000) · Current Atherosclerosis Reports · doi:10.1007/s11883-000-0046-8 · Cited by 1,386
Clinical Practice Recommendations
Fowler, M. J. (2011) · Clinical Diabetes · doi:10.2337/diaclin.29.4.163 · Cited by 996
Rimm, E. B., Stampfer, M. J., Giovannucci, E. L., Ascherio, A., Spiegelman, D. L., Colditz, G. A., & Willett, W. C. (1995) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117385 · Cited by 840
Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes
Laing, S. P., Swerdlow, A. J., Slater, S. D., Burden, A. C., Morris, A., Waugh, N. R., Gatling, W., Bingley, P. J., & Patterson, C. C. (2003) · Diabetologia · doi:10.1007/s00125-003-1116-6 · Cited by 724
A desktop guide to Type 2 diabetes mellitus
European Diabetes Policy Group, 1. (1999) · Diabetic Medicine · doi:10.1046/j.1464-5491.1999.00166.x · Cited by 670
[The Da Qing IGT and Diabetes study].
Ayame, H. (2005) · PubMed · Cited by 658
Intentional weight loss and mortality among overweight individuals with diabetes.
Williamson, D. F., Thompson, T. J., Thun, M. J., Flanders, D. W., Pamuk, E. R., & Byers, T. (2000) · Diabetes Care · doi:10.2337/diacare.23.10.1499 · Cited by 555
Elevated Risk of Cardiovascular Disease Prior to Clinical Diagnosis of Type 2 Diabetes
Hu, F. B., Stampfer, M. J., Haffner, S. M., Solomon, C. G., Willett, W. C., & Manson, J. E. (2002) · Diabetes Care · doi:10.2337/diacare.25.7.1129 · Cited by 552
Jung, R. T. (1997) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a011615 · Cited by 372
Clinical Practice Recommendations
Fowler, M. J. (2009) · Clinical Diabetes · doi:10.2337/diaclin.27.4.160 · Cited by 364
Obesity, weight loss and prognosis in type 2 diabetes
Lean, M. E. J., Powrie, J. K., Anderson, A. S., & Garthwaite, P. H. (1990) · Diabetic Medicine · doi:10.1111/j.1464-5491.1990.tb01375.x · Cited by 318
Henry, R. R., Wiest-Kent, T. A., SCHEAFFER, L., Kolterman, O., & Olefsky, J. M. (1986) · Diabetes · doi:10.2337/diabetes.35.2.155 · Cited by 192
The implementation of nutritional advice for people with diabetes
Nutrition Subcommittee of the Diabetes Care Advisory Committee of Diabetes UK (2003) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.01104.x · Cited by 171
A desktop guide to Type 2 diabetes mellitus. European Diabetes Policy Group 1999.
(1999) · PubMed · Cited by 127
American Diabetes Association: clinical practice recommendations 1997.
(1997) · PubMed · Cited by 116
A Prospective Study of Obesity and Risk of Coronary Heart Disease Among Diabetic Women
Cho, E., Manson, J. E., Stampfer, M. J., Solomon, C. G., Colditz, G. A., Speizer, F. E., Willett, W. C., & Hu, F. B. (2002) · Diabetes Care · doi:10.2337/diacare.25.7.1142 · Cited by 110
Should surgeons treat diabetes in severely obese people?
Pinkney, J. H., Sjöström, C. D., & Gale, E. A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04524-4 · Cited by 71
Self-citationMulti-centre Study (1988) · Diabetic Medicine · doi:10.1111/j.1464-5491.1988.tb01025.x · Cited by 37
Prevention and cure of type 2 diabetes
Pinkney, J. H. (2002) · BMJ · doi:10.1136/bmj.325.7358.232 · Cited by 34
Self-citationWinocour, P. H., Mearing, C., Ainsworth, A. D., & Williams, D. R. R. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.19.s4.7.x · Cited by 10
(2004) · CRC Press eBooks · doi:10.3109/9780203640562 · Cited by 4
Research works printed but not linked: 4
- Department of Health, Health survey for England 2002
- National Institute for Health and Clinical Excellence, Full guidelines for type 2 diabetes: management of blood glucose 2001
- National Institute for Health and Clinical Excellence, Full guidelines for type 2 diabetes: blood pressure management 2002
- National Institute for Health and Clinical Excellence, Full guidelines for type 2 diabetes: lipids management 2002
Cited by
Sorted by citations
Ahmad, E., Lim, S., Lamptey, R., Webb, D. R., & Davies, M. J. (2022) · The Lancet · doi:10.1016/s0140-6736(22)01655-5 · Cited by 1,120
Obesity, Inflammation, Toll-Like Receptor 4 and Fatty Acids
Rogero, M. M., & Calder, P. C. (2018) · Nutrients · doi:10.3390/nu10040432 · Cited by 748
Jelleyman, C., Yates, T., O'Donovan, G., Gray, L. J., King, J. A., Khunti, K., & Davies, M. J. (2015) · Obesity Reviews · doi:10.1111/obr.12317 · Cited by 588
Thingholm, L. B., Rühlemann, M. C., Koch, M., Fuqua, B. K., Laucke, G., Böhm, R., Bang, C., Franzosa, E. A., Hübenthal, M., Rahnavard, A., et al. (2019) · Cell Host & Microbe · doi:10.1016/j.chom.2019.07.004 · Cited by 455
Prevalence of Diabetes Mellitus in a Saudicommunity
Alqurashi, K. A., Aljabri, K. S., & Bokhari, S. (2011) · Annals of Saudi Medicine · doi:10.4103/0256-4947.75773 · Cited by 422
Metadata
- Authors
- Daousi, C., Casson, I. F., Gill, G. V., MacFarlane, I. A., Wilding, J. P. H., & Pinkney, J. H.
- Affiliations
- Aintree University Hospital (GB)
- Corresponding author
- Daousi, C
- Venue
- Postgraduate Medical Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-04-01
- Volume
- 82
- Issue
- 966
- Pages
- 280-284
- ISSN
- 0032-5473 (ISSN-L)
- 1469-0756
- PMC
- PMC2579635
- OpenAlex
- W2120471801
- Cited by
- 351
- References
- 35
- Citations by year
- 2026: 9 · 2025: 22 · 2024: 17 · 2023: 23 · 2022: 25 · 2021: 24 · 2020: 29 · 2019: 30 · 2018: 17 · 2017: 20 · 2016: 18 · 2015: 20 · 2014: 16 · 2013: 21 · 2012: 12
- FWCI
- 5.68
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Postgraduate Medical Journal (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- obesity, type 2 diabetes, type 1 diabetes, overweight prevalence, body mass index, cardiovascular risk factors, glycemic control, blood pressure, lipid profile, morbid obesity, weight gain, antihypertensive drugs, lipid-lowering drugs
- MeSH terms
- Adult, Aged, Blood Pressure, Cardiovascular Diseases, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Diabetic Angiopathies, Female, Humans, Lipids, Male, Middle Aged, Obesity, Obesity, Morbid, Outpatient Clinics, Hospital, Risk Factors, Body Mass Index
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
